Trials / Recruiting
RecruitingNCT04659317
Opioid-Free Orthopaedics
A Double-Blinded Randomized Controlled Trial Examining Multimodal Opioid-Free Orthopaedic Procedures
- Status
- Recruiting
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 80 (estimated)
- Sponsor
- Emory University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this investigation is to compare effectiveness of this multimodal regimen at controlling postoperative pain with and without the use of opioid medications.
Detailed description
Prolonged opioid usage after orthopaedic surgery is an important consideration for both the opioid epidemic and postoperative outcomes. The investigators have developed a multimodal pain control regimen designed to decrease or even potentially eliminate the need for opioids after an orthopedic procedure. This is a prospective double blinded randomized controlled trial utilizing a multimodal pain regimen consisting of education and our standard multimodal pain control regimen. Then, the plan is to randomize patients to receive either encapsulated opioids or placebo. The team will assess patient's pain levels, satisfaction, opioid usage, side effects, patient reported outcomes, and complications. This study will serve as a foundation for future opioid-free surgeries and investigations, while helping to identify patients and factors at risk for prolonged opioid usage postoperatively.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Oxycodone 5 mg Oral Tablet | Encapsulated Oxycodone 5 mg tablets x24, to take po q6 hours as needed |
| DRUG | Placebo oral tablet | Encapsulated placebo tablets x24, to take po q6 hours as need for pain |
Timeline
- Start date
- 2020-12-11
- Primary completion
- 2028-12-01
- Completion
- 2028-12-01
- First posted
- 2020-12-09
- Last updated
- 2025-04-10
Locations
3 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04659317. Inclusion in this directory is not an endorsement.